drug
gilteritinib fumarate
Marketedupdated 3mo agoby Astellas Pharma US Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 28, 2030
~4.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Jul 1, 2036formulationUS 10786500
- Jul 1, 2036formulationUS 11938130
- Jul 1, 2036formulationUS 11938131
- Jul 1, 2036formulationUS 11938132
- Jul 1, 2036formulationUS 11938133
- Jul 1, 2036formulationUS 11944620
- Nov 28, 2032compositionUS 8969336
- Jul 28, 2030method-of-use (U-2456)US 94874914.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that